Switch to:
Streamline Health Solutions, Inc. (NAS:STRM)
Research and Development
$4.74 Mil (TTM As of Oct. 2013)

This is the expense the company spent on research and development. Streamline Health Solutions, Inc.'s research and development for the three months ended in Oct. 2013 was $1.37 Mil. Its research and development for the trailing twelve months (TTM) ended in Oct. 2013 was $4.74 Mil.


Definition

This is the expense the company spent on research and development.

Streamline Health Solutions, Inc. Research & Development for the trailing twelve months (TTM) ended in Oct. 2013 was 1.114 (Jan. 2013 ) + 1.097 (Apr. 2013 ) + 1.16 (Jul. 2013 ) + 1.37 (Oct. 2013 ) = $4.74 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Streamline Health Solutions, Inc. Annual Data

Jan04Jan05Jan06Jan07Jan08Jan09Jan10Jan11Jan12Jan13
Research & Development 2.052.062.732.723.132.261.681.761.412.95

Streamline Health Solutions, Inc. Quarterly Data

Jul11Oct11Jan12Apr12Jul12Oct12Jan13Apr13Jul13Oct13
Research & Development 0.340.300.350.460.510.871.111.101.161.37
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide